Company: NIVFW
Filing Date: 2025-04-03
Form Type: 6-K
Source: 0001213900-25-028370
Chunk: 0

Company: NewGenIvf Group Ltd
Filing Date: 2025-04-03
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2025

Commission File Number: 001-42004

NEWGENIVF GROUP LIMITED

36/39-36/40, 13th Floor, PS Tower

Sukhumvit 21 Road (Asoke)

Khlong Toei Nuea Sub-district

Watthana District, Bangkok 10110

Thailand

(Address of Principal Executive Offices)</div>

Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.

<div align='center'>Form 20-F ☒ Form
40-F ☐

EXPLANATORY NOTE</div>

Additional Debt Financing

On April 1, 2025, the NewGenIvf Group Limited (“Company”) entered into a Securities Purchase Agreement with certain investors named therein (collectively, the “Buyers”), pursuant to which, amongst other things:

(i) the Company agreed to sell, at an initial closing with a certain institutional investor (the “Investor” and such initial closing, the “Initial Closing”), pursuant to which the Company agreed to sell to Investor (a) a senior convertible note (the “Initial Note”) in the aggregate original principal amount not exceeding $3,200,000).

(ii) the Company may require
each Buyer (or each Buyer may require the Company, as applicable) to participate in the sale of (a) one or more additional convertible
notes (which aggregate original principal amount for all additional convertible notes shall not exceed $25,600,000) (the “Additional
Notes,” and, together with the Initial Note, the “Notes”).

In connection with the Notes,
the Company entered into a registration rights agreement, pursuant to which the Company agrees to provide certain registration rights
with respect to the shares underlying the Notes. The form of the registration rights agreement is included as Exhibit C in the Securities
Purchase Agreement filed with this current report on Form 6-K (this “Report”) as Exhibit 4.1. Capitalized terms used in this
Report but not otherwise defined have the meanings set forth in the Securities Purchase Agreement.

The Securities Purchase Agreement